Compound ID | 1891
Class: Beta-lactam (cephalosporin, second generation)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and against many Enterobacteriaceae; less vulnerable to extended-spectum beta-lactamases (ESBL) |
| Description: | Semisynthetic Cephalosporin (cephamycin), derived from Cephalosporin C |
| Year first mentioned: | 1979 |
| Highest developmental phase: | Approved by FDA in 1989 |
| Development status: | Discontinued |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/42008 |
| Guide to Pharmacology: | cefmetazole |
| Citations: |
|